Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 302Carcinoma, Non-Small-Cell Lung 237Prostatic Neoplasms 194Neoplasms 186Lung Neoplasms 145Multiple Myeloma 140Neoplasm Metastasis 107Colorectal Neoplasms 104Melanoma 93Ovarian Neoplasms 88Leukemia, Myeloid, Acute 80Pancreatic Neoplasms 77Lymphoma 73Leukemia, Lymphocytic, Chronic, B-Cell 69Brain Neoplasms 67Carcinoma, Renal Cell 66Lymphoma, Non-Hodgkin 64Squamous Cell Carcinoma of Head and Neck 62Carcinoma, Hepatocellular 59Urinary Bladder Neoplasms 58Hematologic Neoplasms 57Recurrence 56Head and Neck Neoplasms 56Triple Negative Breast Neoplasms 55Glioblastoma 52Endometrial Neoplasms 51Lymphoma, Follicular 50Uterine Cervical Neoplasms 49Sarcoma 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 46

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Infiltrating Bladder Urothelial Carcinoma × 90 days × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡